Table 2.

Patients with at least one serious adverse event in the study group as a whole (overall) and according to disease outcome (complete, partial, or no remission)

Serious Adverse EventOverallComplete RemissionPartial RemissionNo Remission
  acute MI2002
  acute MIb1010
  • The incidence of events in participants with complete remission was lower than in those with partial or no remission (P=0.037, Cochran–Armitage test for trend). MI, myocardial infarction; TIA, transitory ischemic attack.

  • a Lung cancer.

  • b Event during a relapse of nephrotic syndrome.

  • c Breast and prostate cancer.